X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3042) 3042
Publication (233) 233
Newsletter (32) 32
Book Chapter (30) 30
Book Review (21) 21
Book / eBook (9) 9
Magazine Article (5) 5
Conference Proceeding (4) 4
Newspaper Article (3) 3
Paper (2) 2
Web Resource (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1813) 1813
animals (1046) 1046
index medicus (1032) 1032
male (1025) 1025
female (1005) 1005
ketones (634) 634
ketones - therapeutic use (599) 599
adult (515) 515
middle aged (501) 501
mice (400) 400
rats (395) 395
aged (346) 346
metabolism (288) 288
apoptosis (279) 279
pharmacology & pharmacy (277) 277
insulin - therapeutic use (260) 260
amino acid chloromethyl ketones - pharmacology (259) 259
research (254) 254
ketone bodies - blood (237) 237
medicine (235) 235
ketogenic diet (230) 230
child (227) 227
oncology (222) 222
treatment outcome (217) 217
adolescent (215) 215
apoptosis - drug effects (211) 211
cancer (206) 206
glucose (202) 202
research article (197) 197
ketone bodies (188) 188
furans - therapeutic use (186) 186
health aspects (178) 178
antineoplastic agents - therapeutic use (174) 174
biochemistry & molecular biology (174) 174
ketones - pharmacology (174) 174
blood glucose - metabolism (169) 169
multidisciplinary sciences (169) 169
endocrinology & metabolism (166) 166
ketone bodies - metabolism (166) 166
neurosciences (164) 164
analysis (162) 162
chemistry, medicinal (160) 160
care and treatment (159) 159
time factors (159) 159
proteins (157) 157
child, preschool (156) 156
clinical neurology (154) 154
ketone-bodies (149) 149
physiological aspects (148) 148
breast neoplasms - drug therapy (147) 147
blood glucose - analysis (146) 146
diet (143) 143
cell biology (141) 141
chemistry (137) 137
ketones - chemistry (133) 133
chemotherapy (132) 132
insulin (131) 131
cell line, tumor (130) 130
diabetes (129) 129
ketones - adverse effects (129) 129
disease models, animal (128) 128
caspase inhibitors (127) 127
insulin - blood (127) 127
article (126) 126
oxidative stress (126) 126
science (126) 126
epilepsy (125) 125
organic compounds (125) 125
brain (124) 124
rodents (121) 121
chemistry, multidisciplinary (120) 120
activation (114) 114
ketones - administration & dosage (112) 112
ketones - blood (112) 112
biochemistry (108) 108
dose-response relationship, drug (108) 108
infant (108) 108
therapy (108) 108
fatty acids, nonesterified - blood (107) 107
rats, sprague-dawley (106) 106
beta-hydroxybutyrate (103) 103
enzymes (102) 102
breast neoplasms - pathology (100) 100
surgery (100) 100
fatty acids (99) 99
physiology (98) 98
studies (98) 98
mitochondria (97) 97
anticonvulsants - therapeutic use (96) 96
breast cancer (95) 95
liver (95) 95
amino acid chloromethyl ketones - therapeutic use (94) 94
steroids (94) 94
toxicology (94) 94
clinical trials as topic (93) 93
biology (92) 92
caspases - metabolism (92) 92
liver - metabolism (92) 92
structure-activity relationship (92) 92
expression (91) 91
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2823) 2823
German (89) 89
French (48) 48
Japanese (44) 44
Italian (35) 35
Russian (22) 22
Spanish (19) 19
Polish (9) 9
Czech (8) 8
Chinese (6) 6
Danish (3) 3
Portuguese (3) 3
Croatian (2) 2
Dutch (2) 2
Hebrew (2) 2
Hungarian (2) 2
Bulgarian (1) 1
Slovak (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drugs, ISSN 0012-6667, 11/2015, Volume 75, Issue 17, pp. 1993 - 2016
Through years of evolutionary selection pressures, organisms have developed potent toxins that coincidentally have marked antineoplastic activity. These... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | IMMUNOTOXIN RFB4(DSFV)-PE38 BL22 | PEGYLATED LIPOSOMAL DOXORUBICIN | EPOTHILONE-B ANALOG | DRUG-RESISTANT PHENOTYPE | GEMTUZUMAB OZOGAMICIN | PHASE-I TRIAL | METASTATIC BREAST-CANCER | ERIBULIN MESYLATE E7389 | PHARMACOLOGY & PHARMACY | TOXICOLOGY | ANTI-MESOTHELIN IMMUNOTOXIN | CHRONIC MYELOID-LEUKEMIA | Dioxoles - therapeutic use | Diphtheria Toxin - pharmacology | Recombinant Fusion Proteins - pharmacology | Furans - pharmacology | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Epothilones - pharmacology | Drug Discovery - methods | Antineoplastic Agents - therapeutic use | Biological Products - pharmacology | Epothilones - therapeutic use | Harringtonines - therapeutic use | Furans - therapeutic use | TOR Serine-Threonine Kinases - antagonists & inhibitors | Diphtheria Toxin - therapeutic use | Immunoconjugates - pharmacology | Cytochalasins - pharmacology | Dioxoles - pharmacology | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Ketones - therapeutic use | Cytochalasins - therapeutic use | Biological Products - therapeutic use | Ketones - pharmacology | Tetrahydroisoquinolines - pharmacology | Tetrahydroisoquinolines - therapeutic use | Withanolides - pharmacology | Harringtonines - pharmacology | Interleukin-2 - pharmacology | Withanolides - therapeutic use | Antimitotic agents | Care and treatment | Chemotherapy | Usage | Clinical trials | Dosage and administration | Diagnosis | Antineoplastic agents | Cancer | Index Medicus | Review
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10028, pp. 1629 - 1637
Journal Article
Journal Article
Journal Article